KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Receivables - Other: 2019-2024

Historic Receivables - Other for Xenon Pharmaceuticals (XENE) over the last 2 years, with Dec 2024 value amounting to $1.5 million.

  • Xenon Pharmaceuticals' Receivables - Other was N/A to $812,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $812,000, marking a year-over-year change of. This contributed to the annual value of $1.5 million for FY2024, which is N/A change from last year.
  • Per Xenon Pharmaceuticals' latest filing, its Receivables - Other stood at $1.5 million for FY2024, which was up 227.90% from $448,000 recorded in FY2019.
  • In the past 5 years, Xenon Pharmaceuticals' Receivables - Other ranged from a high of $1.5 million in FY2024 and a low of $1.5 million during FY2024.
  • For the 1-year period, Xenon Pharmaceuticals' Receivables - Other averaged around $1.5 million, with its median value being $1.5 million (2024).